FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a method of preparing a compound of Formula I or a salt thereof, where R1 represents either aryl or pyridyl, optionally substituted with one or more groups selected from halogen, -CN, -C(O)NR3R4, -S(O)2R5; C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, where the last three groups are optionally substituted with one or more F; R2 represents C1-6 alkyl, optionally substituted by one or more F; each R3 and R4 independently represents either H or C1-6 alkyl, optionally substituted with one or more F; R5 represents C1-6 alkyl, optionally substituted with one or more F; wherein the said process comprises the following steps: (i) forming a compound of Formula II, wherein R1 and R2 are as specified for a compound of Formula I, and R6 is C1-6 alkyl, optionally substituted with one or more F or phenyl, optionally substituted with one or more groups selected from halogen, methyl and -NO2 by contacting a compound of Formula III with a suitable sulfonating agent in the presence of a suitable base B1 and a suitable solvent S1, wherein S1 is the solvent in which the salt formed between B1 and the leaving group of the sulfonating agent is insoluble, and then (ii) contacting a compound of Formula II with a compound of Formula IV, wherein M+ is either Li+, Na+, K+ or Cs+, and where the compound of Formula III is presented as a single enantiomer. The invention also relates to a method of producing a compound of formula (VII), including a method of producing a compound of formula (I).
EFFECT: method has been developed for obtaining a compound of formula (I) with high yield and degree of chiral purity.
27 cl, 2 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
PHOSPHATE AND PHOSPHONATE DERIVATIVES OF 7-AMINO-5-THIOTHIAZOLO[4,5-d]PYRIMIDINES AND THEIR USE FOR THE TREATMENT OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH ELEVATED LEVELS OF CX3CR1 AND/OR CX3CL1 | 2019 |
|
RU2801664C2 |
METHOD OF PRODUCING PYRIMIDINYLCYCLOPENTANE COMPOUNDS | 2014 |
|
RU2826179C2 |
METHOD OF PRODUCING PYRIMIDINYLCYCLOPENTANE COMPOUNDS | 2014 |
|
RU2702355C1 |
5-(7H-PYRROLO[2,3-d]PYRIMIDINE-4-YL)-5-AZASPIRO[2.5]OCTANE-8-CARBOXYLIC ACID DERIVATIVES AS NEW JAK-KINASE INHIBITORS | 2018 |
|
RU2761626C2 |
METHODS OF PRODUCING (CYCLOPENTYL[D]PYRIMIDIN-4-YL)PIPERAZINE COMPOUNDS | 2015 |
|
RU2732404C2 |
ARYLCYCLOPROPYLAMINE BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE | 2011 |
|
RU2611437C2 |
METHODS OF PRODUCING (CYCLOPENTYL[D]PYRIMIDIN-4-YL)PIPERAZINE COMPOUNDS | 2015 |
|
RU2712224C2 |
NOVEL DERIVATIVES OF 2,3-DIHYDRO-1H-IMIDAZO[1,2-a]PYRIMIDIN-5-ONE, METHOD OF OBTAINING THEREOF AND APPLICATION IN PHARMACY | 2010 |
|
RU2554868C2 |
METHOD FOR PRODUCTION OF HYDROXYLATED CYCLOPENTYL PYRIMIDINE COMPOUNDS | 2013 |
|
RU2643811C2 |
METHOD FOR PRODUCTION OF OXASPIROCYCLIC DERIVATIVE AND ITS INTERMEDIATE COMPOUND | 2018 |
|
RU2777983C2 |
Authors
Dates
2024-02-12—Published
2019-05-15—Filed